[Federal Register Volume 87, Number 238 (Tuesday, December 13, 2022)]
[Notices]
[Page 76207]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26996]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Sickle Cell Disease
Advisory Committee.
The meeting will be open to the public through a virtual meeting.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the Contact Person listed below in advance of the meeting.
Name of Committee: Sickle Cell Disease Advisory Committee.
Date: January 30, 2023.
Time: 10:00 a.m. to 2:30 p.m.
Agenda: Research, engagement and representation from the
community.
Place: National Institutes of Health, Rockledge 1, 6705
Rockledge Dr, Bethesda, MD 20892, (Virtual Meeting--Teleconference
andZoomGov).
Telephone Access: +1 669 254 5252 (Meeting ID 160 763 2658).
Virtual Access: https://nih.zoomgov.com/j/1607632658, (Meeting
ID: 160 763 2658).
Contact Person: Nahed El Kassar, MD, Ph.D. Medical Officer
National Heart, Lung, and Blood Institute, Blood Epidemiology &
Clinical Therapeutics Branch, Division of Blood Diseases and
Resources, 6701 Rockledge Drive, Suite 9166, Bethesda, MD 20892,
301-435-0080, [email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: December 8, 2022.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-26996 Filed 12-12-22; 8:45 am]
BILLING CODE 4140-01-P